PAPER Coburger I, Hoefgen S, Than ME
SEARCH RESULTS
331209 RESULTS
PAPER Vignini A, Morganti S, Salvolini E, Sartini D, Luzzi S, Fiorini R, Provinciali L, Di Primio R, Mazzanti L, Emanuelli M
Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and Frontotemporal lobar degeneration: A Real-time PCR study.
Exp Gerontol. 2013 Oct 26; PubMed: 24513653PAPER Bandyopadhyay S, Rogers JT
Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.
Biochem Pharmacol. 2014 Apr 15;88(4):486-94. Epub 2014 Feb 7 PubMed: 24513321PAPER Hong L, Huang HC, Jiang ZF
Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.
Neurol Res. 2014 Mar;36(3):276-82. PubMed: 24512022PAPER Valastyan JS, Termine DJ, Lindquist S
Splice isoform and pharmacological studies reveal that sterol depletion relocalizes α-synuclein and enhances its toxicity.
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3014-9. Epub 2014 Feb 10 PubMed: 24516169PAPER Takano M, Tashiro E, Kitamura A, Maita H, Iguchi-Ariga SM, Kinjo M, Ariga H
Prefoldin prevents aggregation of α-synuclein.
Brain Res. 2013 Oct 25; PubMed: 24513251PAPER Singh N, Haldar S, Tripathi AK, McElwee MK, Horback K, Beserra A
Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
Antioxid Redox Signal. 2014 Jul 20;21(3):471-84. Epub 2014 Feb 27 PubMed: 24512387PAPER Woollacott IO, Mead S
The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues.
Acta Neuropathol. 2014 Mar;127(3):319-32. Epub 2014 Feb 11 PubMed: 24515836PAPER Stribl C, Samara A, Trümbach D, Peis R, Neumann M, Fuchs H, Gailus-Durner V, Hrabě de Angelis M, Rathkolb B, Wolf E, Beckers J, Horsch M, Neff F, Kremmer E, Koob S, Reichert AS, Hans W, Rozman J, Klingenspor M, Aichler M, Walch AK, Becker L, Klopstock T, Glasl L, Hölter SM, Wurst W, Floss T
Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43.
J Biol Chem. 2014 Apr 11;289(15):10769-84. Epub 2014 Feb 10 PubMed: 24515116PAPER Kasai M, Meguro K
Estimated quality-adjusted life-year associated with the degree of activities of daily living in patients with Alzheimer's disease.
Dement Geriatr Cogn Dis Extra. 2013 Jan;3(1):482-8. Epub 2013 Dec 14 PubMed: 24516416PAPER Degerman Gunnarsson M, Lindau M, Santillo AF, Wall A, Engler H, Lannfelt L, Basun H, Kilander L
Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.
Dement Geriatr Cogn Dis Extra. 2013 Jan;3(1):472-81. Epub 2013 Dec 14 PubMed: 24516415PAPER Idrizbegovic E, Hederstierna C, Dahlquist M, Rosenhall U
Short-term longitudinal study of central auditory function in Alzheimer's disease and mild cognitive impairment.
Dement Geriatr Cogn Dis Extra. 2013 Jan;3(1):468-71. Epub 2013 Dec 14 PubMed: 24516414PAPER Paajanen T, Hänninen T, Aitken A, Hallikainen M, Westman E, Wahlund LO, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H, AddNeuroMed Consortium
CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease.
Dement Geriatr Cogn Dis Extra. 2013 Jan;3(1):446-58. Epub 2013 Nov 30 PubMed: 24516412PAPER Ponnayyan Sulochana S, Sharma K, Mullangi R, Sukumaran SK
Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease.
Biomed Chromatogr. 2014 Feb 11; PubMed: 24515838PAPER Kaiser NC, Liang LJ, Melrose RJ, Wilkins SS, Sultzer DL, Mendez MF
Differences in anxiety among patients with early- versus late-onset Alzheimer's disease.
J Neuropsychiatry Clin Neurosci. 2014;26(1):73-80. PubMed: 24515678Current Filters
No filters selected